2. LQDA: Liquidia Corp. (LQDA) climbs 26.59% after settling a years-long legal dispute with United Therapeutics related to patents, trade secrets, contracts, and antitrust claims over its lung disease drug.
2. LQDA: Liquidia Corp. (LQDA) climbs 26.59% after settling a years-long legal dispute with United Therapeutics related to patents, trade secrets, contracts, and antitrust claims over its lung disease drug.